Faster Diagnostics secures £250k to advance early breast cancer detection

Developing blood-based tests to improve the early detection of breast cancer is the primary focus of London-based Faster Diagnostics Ltd. The company targets women aged 25 and older, primarily in the UK, using research and survey initiatives to support its diagnostic tool development. Its mission involves shaping the future of screening through its website at fasterdiagnostics.com.

A recent funding round has raised an estimated £250k for the business. This capital injection values the startup at approximately £20.1m on a post-money basis.

Incorporated in 2024, the firm operates within the hospitals and healthcare sector and currently lists one employee. Its most recent financial accounts were prepared for the year ended 31 January 2025. Formal documentation for the share allotment was filed in September (following an initial allotment in April).